Document:

Exhibit
10.59

Agreement
between Value Quest Inc. and Entest BioMedical Inc.

 

Agreement
by and between Value Quest Inc. ("Consultant"), whose address is at East Chase Street, St 1103, Baltimore, MD 21202
and Entest BioMedical Inc. ("Company"), a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California
91942 made as of July 17, 2017.

 

WHEREAS
the Company desires to engage the Consultant to assist the Company with sourcing,

compliance
review and quality control in identifying a veterinary contract research organization

(VCRO)
to conduct various research project sponsored by the Company.

 

WHEREAS,
Consultant desires to assist the Company with sourcing, compliance review and quality control in identifying a veterinary contract
research organization (VCRO) to conduct various research project sponsored by the Company.

 

NOW,
THEREFORE, it is agreed as follows:

 

1.       The
respective duties and obligations of the contracting panies shall be for a period of f ur months commencing on the date of this
Agreement.

2.       Consultant
shall receive on or prior to July 25, 2017 as full consideration for the services

to-be
rendered 2,000 000 newly is-sued common shares of the Company's stock.

3.       Independent
Contractor Status. The Company and the Consultant hereby agree that the Consultant is being retained by the Company in the capacity
of an independent contractor and not as an employee or agent of the Company. the Company and the Consultant further agree that
nothing in this Agreement shall create, or shall be construed as creating, any form of partnership, joint venture, or other affiliation
that would operate to permit- the Consultant to bind the Company with respect to any matter or would cause the Company to be liable
for any action of the Finder, and the Consultant hereby agrees that it will not represent to any third party that its engagement
by the Company is in any capacity other than as an independent contractor.

4.       Entire
Agreement. This Agreement contains the entire understanding between the parties hereto concerning the subject matter contained
herein. There are no representations, agreements, arrangements, or understandings, oral or written, between or among the parties
hereto relating to the subject matter of this Agreement that are not fully expressed herein.

5.       Governing
Law: Venue. This Agreement has been executed in and shall be governed by

the
laws of the state of California, without giving effect to the conflict of laws rules thereof or of any state. Venue for any action
brought hereunder shall be proper only in San Diego county, California.

 

IN
WITNESS WHEREOF, the parties to this Agreement have set their respective hands hereto

As
of the date first written above

 

Consultant
Company

/s/Jim
Hibbart /s/David R. Koos

Jim
Hibbart, PresidentExhibit
10.60

 

AGREEMENT
BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC.

Dated
September 12, 2017

 

WHEREAS,
REGEN BIOPHARMA, INC. (“REGEN”) AND ZANDER THERAPEUTICS, INC. (“ZANDER”) ARE PARTIES TO THAT AGREEMENT
DATED JUNE 23, 2015 WITH ZANDER WHEREBY REGEN GRANTED TO ZANDER AN EXCLUSIVE WORLDWIDE RIGHT AND LICENSE FOR THE DEVELOPMENT AND
COMMERCIALIZATION OF CERTAIN INTELLECTUAL PROPERTY CONTROLLED BY REGEN (“LICENSE AGREEMENT”).

WHEREAS
REGEN AND ZANDER WISH TO ADD TO THE INTELLECTUAL PROPERTY FOR WHICH AN EXCLUSIVE WORLDWIDE RIGHT AND LICENSE FOR THE DEVELOPMENT
AND COMMERCIALIZATION HAS BEEN GRANTED TO ZANDER BY REGEN

THEREFORE
IT IS AGREED AS FOLLOWS:

EXHIBIT
A OF THE LICENSE AGREEMENT SHALL BE AND READ:

Exhibit
A

Any
and all intellectual property controlled by Regen Biopharma, Inc. exclusive of trademarks 

 

EACH
PARTY HEREBY IS DULY ORGANIZED, VALIDLY EXISTING AND IN GOOD STANDING UNDER THE LAWS OF THEIR RESPECTIVE JURISDICTION. EACH PARTY
HAS THE FULL RIGHT AND POWER TO ENTER INTO AND PERFORM ITS OBLIGATIONS UNDER THIS AGREEMENT AND EACH HAS DULY AUTHORIZED, EXECUTED
AND DELIVERED THIS AGREEMENT WHICH IS BINDING UPON, AND ENFORCEABLE AGAINST, EACH PARTY IN ACCORDANCE WITH ITS TERMS. TO THE BEST
KNOWLEDGE OF EACH PARTY THERE IS NO ACTION AT LAW OR IN EQUITY, NO ARBITRATION PROCEEDING AND NO ACTION, PROCEEDING, COMPLAINT
OR INVESTIGATION BEFORE OR BY ANY FEDERAL, FOREIGN, STATE OR LOCAL GOVERNMENT OR REGULATORY COMMISSION, AGENCY OR OTHER ADMINISTRATIVE
OR REGULATORY BODY OR AUTHORITY PENDING OR THREATENED AGAINST OR AFFECTING EITHER PARTY ITS OFFICERS, DIRECTORS, BUSINESS OR AFFAIRS
THAT WILL AFFECT THE SET OVER OF THE ASSIGNED PATENT AND THE EQUITABLE CONSIDERATION, AS STATED HEREIN.

ALL
QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED
AND ENFORCED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF CALIFORNIA, WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF
LAW THEREOF. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN CALIFORNIA
FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED
HEREIN AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY
SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER OR INCONVENIENT VENUE FOR SUCH
PROCEEDING. IF EITHER PARTY SHALL COMMENCE AN ACTION OR PROCEEDING TO ENFORCE ANY PROVISIONS OF THIS AGREEMENT, THEN THE PREVAILING
PARTY IN SUCH ACTION

	 	1	 

    	 

    	 

    

 

OR
PROCEEDING SHALL BE REIMBURSED BY THE OTHER PARTY FOR ITS ATTORNEYS’ FEES AND OTHER COSTS AND EXPENSES INCURRED WITH THE
INVESTIGATION, PREPARATION AND PROSECUTION OF SUCH ACTION OR PROCEEDING.

ALL
QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED
AND ENFORCED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF CALIFORNIA, WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF
LAW THEREOF. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN CALIFORNIA
FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED
HEREIN AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY
SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER OR INCONVENIENT VENUE FOR SUCH
PROCEEDING. IF EITHER PARTY SHALL COMMENCE AN ACTION OR PROCEEDING TO ENFORCE ANY PROVISIONS OF THIS AGREEMENT, THEN THE PREVAILING
PARTY IN SUCH ACTION OR PROCEEDING SHALL BE REIMBURSED BY THE OTHER PARTY FOR ITS ATTORNEYS’ FEES AND OTHER COSTS AND EXPENSES
INCURRED WITH THE INVESTIGATION, PREPARATION AND PROSECUTION OF SUCH ACTION OR PROCEEDING.

 

	REGEN
    BIOPHARMA INC. 	ZANDER
    THERAPEUTICS INC.
	 	 
	By:
    /s/David Koos	By: /s/David
    Koos
	 	 
	David
    R. Koos	David
    R. Koos 
	Chairman
    & CEO 	Chairman
    & CEOExhibit
10.61

This
Business Advisory Board Services Agreement (the “Agreement”), dated June 23, 2017, is entered into between Zander
Therapeutics, Inc., a Nevada corporation (“the Company), and Brian Devine, an individual with a principal place of residence
California(“Candidate”).

WHEREAS,
the Company desires to retain the services of Candidate for the benefit of the Company and its stockholders; and

WHEREAS,
Candidate desires to serve as Chairman of the Company’s Business Advisory Board for the period of time and subject to
the terms and conditions set forth herein;

NOW,
THEREFORE, for consideration and as set forth herein, the parties hereto agree as follows:

	 	1.	Board
    Duties.  Candidate agrees to provide services to the Company as Chairman of the Company’s Business Advisory
    Board. Candidate shall, for so long as he remains a member of the Business Advisory Board, meet with the Company upon written
    request, at dates and times mutually agreeable to Candidate and the Company, to discuss any matter involving the Company or
    its Subsidiaries

 

	 	2.	Other
    Duties. Candidate will utilize his best efforts to:

 

	 	(a)	Identify
    and introduce to the Company persons not previously known to the Company to serve as members of the Company’s Business
    Advisory Board (“Advisory Candidates”).

 

	 	(b)	Identify
    and introduce to the Company potential purchasers of the Company’s securities, such purchasers not previously known
    to the Company (“Buyers”). Candidate shall solely identify and introduce Buyers to the Company and shall not,
    among other things, participate in any negotiations between a Buyer and the Company, assist in the structure of any offer
    or sale of the Company’s securities (“Transaction”), provide assistance to any party in completing a purchase
    agreement, subscription agreement or other documentation related to a Transaction or handle the funds or securities involved
    in any Transaction.

 

	 	3.	Term.
    The Term of this Agreement shall commence on June 23, 2017 and shall expire on June 23, 2020. The term of this Agreement
    may be extended by mutual agreement.

 

	 	4.	Independent
    Contractor. The Parties are independent contractors. Nothing in this Agreement shall be deemed to constitute a partnership
    or joint venture between the Parties or constitute any Party to be the agent of the other Party for any purpose.

 

	 	5.	No
    obligation: This Agreement does not constitute an obligation on the part of the Company to:

 

	 	(a)	Enter
    into any Transaction with any Buyer

 

	 	(b)	Accept
    as a member of the Business Advisory Board any Advisory Candidate

 

	 	1	 

    	 

    	 

    

 

	 	6.	Mutual
    Non-Disparagement. During the term of this Agreement and for a period of twelve months thereafter, Candidate and
    the Company mutually agree to forbear from making, causing to be made, publishing, ratifying or endorsing any and all disparaging
    remarks, derogatory statements or comments made to any party with respect to either of them or their respective officers,
    directors, and employees. The parties agree and acknowledge that this Section 6 is a material term of this Agreement.

 

	 	7.	Non
    Disclosure.

(a)
All information, whether in oral, written, graphic, electronic or other form, disclosed by the Company to the Candidate shall
be deemed to be “Proprietary Information.” In particular, Proprietary Information includes, without limitation, any
trade secrets, confidential information, ideas, inventions or research and development information; matters of a technical nature,
including technology; notes, products, know-how, engineering or other data (including test data and data files); specifications,
processes, techniques, formulae or work-in-process; manufacturing, planning or marketing procedures, clinical data and regulatory
strategies or information; accounting, financial or pricing procedures or information, budgets or projections, or personnel or
salary structure/compensation information; information regarding suppliers, clients, customers, employees, contractors, investors
or investigators of the Company, information which has been designated in writing as confidential by the Company; programs, procedures
(including operating procedures), processes, methods, guidelines, policies, proposals or contracts; computer software, data bases
or programming; and any other information which, if divulged to a third party, could have an adverse impact on the Company, or
on any third party to which it owes a confidentiality obligation. In addition, “Proprietary Information” includes
any of the foregoing relating to the past, present or future operations, organization, projects, finances, business interests,
methodology or affairs of any third party to which the Company owes a duty of confidentiality including, without limitation, the
mere fact that the Company is or may be working with or for any client.

(b)
The obligations of confidentiality shall not apply to any Proprietary Information that was known by the Candidate at the time
of disclosure to it by such Company, or that is independently developed or discovered by the Candidate after disclosure by such
Company, without the aid, application or use of any item of such Company’s Proprietary Information, as evidenced by written
records; now, or subsequently becomes, through no act or failure to act on the part of the Candidate, generally known or available;
is disclosed to the Candidate by a third party authorized to disclose it; or is required by law or by court or administrative
order to be disclosed; provided, that the Candidate shall have first given prompt notice to such Company of such required disclosure.

 

	 	2	 

    	 

    	 

    

 

 

	 	(c)	Candidate
    shall exercise due care to prevent the unauthorized use or disclosure of the Company’s Proprietary Information, and
    shall not, without the Company’s prior written consent, disclose or otherwise make available, directly or indirectly,
    any item of the Company’s Proprietary Information to any person or entity other than those employees, independent contractors
    or agents of the Candidate (collectively, “Representatives”), to the extent such Representatives reasonably need
    to know the same in order to evaluate such Proprietary Information, to participate in the business relationship between the
    parties, or to make decisions or render advice in connection therewith. Candidate shall advise its Representatives who have
    access to the Company’s Proprietary Information of the confidential and proprietary nature thereof, and agrees that
    such Representatives shall be bound by terms of confidentiality and restrictions on use with respect thereto that are at least
    as restrictive as the terms of this Agreement.

 

	 	(d)	Candidate
    shall exercise due care to prevent the unauthorized use or disclosure of the Company’s Proprietary Information, and
    shall not, without the Company’s prior written consent, disclose or otherwise make available, directly or indirectly,
    any item of the Company’s Proprietary Information to any person or entity other than those employees, independent contractors
    or agents of the Candidate (collectively, “Representatives”), to the extent such Representatives reasonably need
    to know the same in order to participate in any business relationship between the parties, or to make decisions or render
    advice in connection therewith. Candidate shall advise its Representatives who have access to the Company’s Proprietary
    Information of the confidential and proprietary nature thereof, and agrees that such Representatives shall be bound by terms
    of confidentiality and restrictions on use with respect thereto that are at least as restrictive as the terms of this Agreement.

 

	 	(e)	Candidate
    shall use the Company’s Proprietary Information solely for the purposes of performing his duties pursuant to this Agreement
    and shall not make any other use of the Company’s Proprietary Information without the Company’s specific written
    authorization.

 

	 	(f)	All
    Proprietary Information of the Company (including all copies thereof) shall be and at all times remain the property of such
    Company, and all non-oral Proprietary Information of the Company which is then in the Candidate’s possession or control
    shall be destroyed or returned to the Company promptly upon its request at any time, and in any event, no later than 60 days
    following any expiration or termination of this Agreement. 

 

	 	(g)	Nothing
    in this Agreement shall be construed, by implication or otherwise, as a grant of any right or license to trademarks, inventions,
    copyrights or patents, as a grant of a license to either Candidate to use any of the Company’s Proprietary Information
    except as expressly set forth herein.

 

	 	(h)	The
    provisions of Section 7 of this Agreement shall survive until such time as all Confidential Information disclosed hereafter
    becomes publically known and made generally available through no action or inaction of Candidate. 

 

	 	8.	Compensation.

 

	 	3	 

    	 

    	 

    

 

	 	(a)	For
    performance of duties pursuant to Section 1 of this Agreement, Candidate will receive, no later than ten days from the execution
    of this Agreement 500,000 of the common shares of the Company.

 

	 	(b)	For
    performance of duties pursuant to Section 2 of this Agreement, Candidate will receive:

 

	 	(i)	In
    the event that an Advisory Candidate identified and introduced by you to the Company serves as a member of the Business Advisory
    Board of the Company, the Candidate shall receive, ten business days subsequent to the completion of 12 months service by
    the Advisory Candidate as a member of the Business Advisory Board of the Company, a 5% referral fee of shares issued to the
    Candidate paid in Common Shares of the Company.

 

	 	9.	Restricted
    Securities Acknowledgement

 

Candidate
acknowledges that any securities issued pursuant to this Agreement that shall not be registered pursuant to the Securities Act
of 1933 shall constitute “restricted securities” as that term is defined in Rule 144 promulgated under the Securities
Act of 1933, and shall contain the following restrictive legend:

“THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR SECURITIES LAWS OF
ANY STATE AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION
UNDER THE ACT OR SUCH LAWS AND, IF REQUESTED BY THE COMPANY, UPON DELIVERY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO
THE COMPANY THAT THE PROPOSED TRANSFER IS EXEMPT FROM THE ACT OR SUCH LAWS.”

	 	10.	Representations
    and Warranties of Company.

a)
Company is a corporation duly organized, validly existing and in good standing under the laws of the state its incorporation and
has the requisite corporate power and authority to enter into and perform its obligations under this Agreement without the consent,
approval or authorization of, or obligation to notify, any person, entity or governmental agency which consent has not been obtained.

 

	 	4	 

    	 

    	 

    

 

	 	(c)	The
    execution, delivery and performance of this Agreement by Company does not and shall not constitute Company’s breach
    of any statute or regulation or ordinance of any governmental authority, and shall not conflict with or result in a breach
    of or default under any of the terms, conditions, or provisions of any order, writ, injunction, decree, contract, agreement,
    or instrument to which the Company is a party, or by which Company is or may be bound.

 

	 	11.	Representation
    and Warranties of the Candidate.

 

(a)
Candidate has the requisite power and authority to enter into and perform his obligations under this Agreement without the consent,
approval or authorization of, or obligation to notify, any person, entity or governmental agency which consent has not been obtained.

(b)
The execution, delivery and performance of this Agreement by Candidate does not and shall not constitute Candidate’s breach
of any statute or regulation or ordinance of any governmental authority, and shall not conflict with or result in a breach of
or default under any of the terms, conditions, or provisions of any order, writ, injunction, decree, contract, agreement, or instrument
to which the Candidate is a party, or by which Candidate is or may be bound.

12.
Execution

This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same Agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood
that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission,
such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed)
with the same force and effect as if such facsimile signature page were an original thereof.

13.
Entire Agreement

This
Agreement constitutes a final written expression of all the terms of the Agreement between the parties regarding the subject matter
hereof, are a complete and exclusive statement of those terms, and supersedes all prior and contemporaneous Agreements, understandings,
and representations between the parties. 

14.
Severability

	 	5	 

    	 

    	 

    

 

If
any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the
remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt
to agree upon a valid and enforceable provision that is a reasonable substitute therefore, and upon so agreeing, shall incorporate
such substitute provision in this Agreement

15.
Governing Law, Venue, Waiver Of Jury Trial

All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed
and enforced in accordance with the internal laws of the State of California, without regard to the principles of conflicts of
law thereof. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in California
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or inconvenient venue for such
proceeding. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing
party in such action or proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses
incurred with the investigation, preparation and prosecution of such action or proceeding.

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

	COMPANY	 	CANDIDATE
	By:/s/
    David R. Koos	 	By:
    /s/ Brian Devine
	David
                                         R. Koos, Chairman and CEO

        Date:
        June 20, 2017
	 	Brian
    Devine
	 	 	 
	 	 	Date:
    June 21, 2017

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}]]